Literatur
-
1
Devereux R B, Alonso D R, Lutas E M. et al .
Echocardiographic
assessment of left ventricular hypertrophy: Comparison to necropsy
findings.
Am J Cardiol.
1986;
57
450-458
-
2
Devereux R B, Dahlöf B, Levy D, Pfeffer M A.
Comparison
of enalapril versus nifedipine to decrease left ventricular hypertrophy
in systemic hypertension (the PRESERVE trial).
Am J Cardiol.
1996;
78
61-65
-
3 Franz I -W. Hypertonie
und Herz. Diagnostische, prognostische und therapeutische Aspekte. Springer,
Berlin 1991
-
4
Franz I -W, Ketelhut R, Behr U, Tönnesmann U.
Time course
of reduction in left ventricular mass during long-term antihypertensive
therapy.
J Human Hypertens.
1994;
8
191-198
-
5
Franz I -W, Tönnesmann U, Müller J FM.
Time course of complete normalization of
left ventricular hypertrophy during long-term antihypertensive therapy
with angiotensin converting enzyme inhibitors.
Am J Hypertens.
1998;
11
631-639
-
6
Franz I -W.
Kann
die linksventrikuläre pathologische Hypertrophie bei arterieller
Hypertonie von einer physiologischen Hypertrophie durch Sport unterschieden
werden?.
Dtsch med Wochenschr.
2002;
5
225-226
-
7
Ganau A, Devereux R B, Roman M J. et al .
Patterns of left ventricular
hypertrophy and geometric remodeling in essential hypertension.
J
Am Coll Cardiol.
1992;
19
1550-1558
-
8
Gueyffier F, Boissel J P, Pocock S. et al .
Identification of risk factors in hypertensive
patients: contribution of randomized controlled trials through an
individual patient database.
Circulation.
1999;
100
e88-e94
-
9
Hammond I W, Devereux R B, Alderman M H. et al .
The prevalence and correlates of
echocardiographic left ventricular hypertrophy among employed patients with
uncomplicated hypertension.
J Am Coll Cardiol.
1986;
7
639-650
-
10
Harrap S B, Dominiczak A F, Fraser R. et al .
Plasma angiotensin II, predisposition to
hypertension and left ventricular size in healthy young adults.
Circulation.
1996;
93
1148-1154
-
11
Koren M J, Devereux R B, Casale P N, Savage D D, Laragh J H.
Relation of left ventricular mass
and geometry to morbidity and mortality in uncomplicated essential hypertension.
Ann
Intern Med.
1991;
114
345-352
-
12
Levy D, Garrison R J, Savage D D, Kannel W B, Castelli W P.
Prognostic implications of echocardiographically
determined left ventricular mass in the Framingham Heart Study.
N
Engl J Med.
1990;
332
1561-1566
-
13
Liao Y, Cooper R S, Durazo-Arvizu R. et al .
Prediction of mortality risk by different
methods of indexation for left ventricular mass.
J Am
Coll Cardiol.
1997;
29
641-647
-
14
Mancia G, Carugo S, Grassi G. et al .
Prevalence of left ventricular hypertrophy
in hypertensive patients without and with blood pressure control.
Data from PAMELA-Population.
Hypertens.
2002;
39
744-749
-
15
Myerson S G, Bellener N G, Pennell D J.
Assessment of left ventricular mass by cardiovascular
magnetic resonance.
Hypertens.
2002;
39
750-755
-
16
Salton C J, Chuang M L, O’Donnel C J. et al .
Gender differences
and normal left ventricular anatomy in an adult population free
of hypertension.
J Am Coll Cardiol.
2002;
39
1055-1060
-
17
Savage D D, Garrison R J, Kannel W B. et al .
The spectrum of left ventricular
hypertrophy in a general population sample: the Framingham study.
Circulation.
1987;
75
(Suppl I)
26-33
-
18
Schillacci G, Verdecchia P, Porcellati C, Cuccumullo O, Lasco C, Perticone F.
Continuous relation
between left ventricular mass and cardiovascular risk in essential
hypertension.
Hypertension.
2000;
35
580-586
Prof. Dr. med. Ingomar-W. Franz
Schwarzenbacher Straße 3
79682 Todtmoos
Phone: 07674/903161
Fax: 07674/903230
Email: wehrawald-bfa@t-online.de
